title: Third generation oral contraceptives--the controversy.
authors.forename: D
authors.initials: D
authors.lastname: Carnall
authors.forename: H
authors.initials: H
authors.lastname: Karcher
authors.forename: L G
authors.initials: LG
authors.lastname: Lie
authors.forename: T
authors.initials: T
authors.lastname: Sheldon
authors.forename: D
authors.initials: D
authors.lastname: Spurgeon
authors.forename: D
authors.initials: D
authors.lastname: Josefson
authors.forename: C
authors.initials: C
authors.lastname: Zinn
mesh_terms: D001294:Attitude to Health; D001315:Australia; D002170:Canada; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects*; D017135:Desogestrel / Q000009:adverse effects*; D005260:Female; D005858:Germany; D006801:Humans; D008402:Mass Media; D009426:Netherlands; D009652:Norpregnenes / Q000009:adverse effects*; D009664:Norway; D013923:Thromboembolism / Q000139:chemically induced*; D006113:United Kingdom; D014481:United States
chemical_list: D003280:Contraceptives, Oral, Synthetic; D009652:Norpregnenes; C033273:Gestodene; D017135:Desogestrel